Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptiNose, Inc. - Common Stock (NQ:OPTN)

9.140 -0.010 (-0.11%)
Streaming Delayed Price Updated: 12:52 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptiNose, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GB, RDFN, PRA, OPTN on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
From Kahn Swick & Foti, LLC
Via Business Wire
Earnings Scheduled For November 12, 2024
Via Benzinga
Insights Ahead: OptiNose's Quarterly Earnings
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Beacon Roofing Supply, Inc. (Nasdaq – BECN), Optinose, Inc. (Nasdaq – OPTN), Corporation (Nasdaq – RDFN), Blackboxstocks Inc. (Nasdaq – BLBX)
From Brodsky & Smith LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
Via Benzinga
Exposures Fossil Fuels
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight
Paratek will acquire Optniose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19. 
Via Stocktwits
Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
OPTN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Optinose, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
OptiNose Stock Is Soaring Today: What's Going On?
OptiNose Inc (NASDAQ:OPTN) shares are trading higher Thursday after Paratek Pharmaceuticals announced a deal to acquire the company. 
Via Benzinga
Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
US Stocks Likely To Open Higher As Fed Says Tariff-Induced Inflation Will Be 'Transitory:' Any Pullback In Equities 'Offers An Opportunity,' Says Expert
U.S. stock futures rose on Thursday following the Federal Open Market Committee's decision on Wednesday calling inflation 'transitory'. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Conference Call and Webcast to be held March 20, 2025, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Monday's pre-market session: top gainers and losers
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
Preliminary XHANCE prescription growth rate from third quarter to fourth quarter 2024 estimated to be approximately 20% 
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces 1-for-15 Reverse Stock Split
From Optinose, Inc.
Via GlobeNewswire
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
From Optinose, Inc.
Via GlobeNewswire
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
Conference Call and Webcast to be held November 12, 2024, at 8:00 a.m. Eastern Time 
From Optinose, Inc.
Via GlobeNewswire
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Optinose, Inc.
Via GlobeNewswire
Optinose Appoints Terry Kohler as Chief Financial Officer
From Optinose, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.